Year: 2018
Type: article
Abstract: Key Points The 3 established HbF genetic loci can be summarized into 1 quantitative variable, g(HbF), in SCD and influence markers of SCD severity. g(HbF) provides a quantitative marker for the genetic component of HbF% variability, potentially useful in genetic and clinical studies in SCD.
Source: Blood Advances
Authors: Kate Gardner, Tony Fulford, Nicholas Silver, Helen Rooks, Nikolaos Angelis, Marlene Allman, Siana Nkya, Julie Makani, Jo Howard, Rachel Kesse-Adu, David C. Rees, Sara Stuart-Smith, Tullie Yeghen, Moji Awogbade, Raphael Z. Sangeda, Josephine Mgaya, Hamel Patel, Stephen Newhouse, Stephan Menzel, Swee Lay Thein
Institutions: National Health Service, King's College London, King's College Hospital NHS Foundation Trust, King's College Hospital, University of Cambridge, Muhimbili University of Health and Allied Sciences, Guy's Hospital, St Thomas' Hospital, Guy's and St Thomas' NHS Foundation Trust, University Hospital Lewisham, Lewisham and Greenwich NHS Trust, South London and Maudsley NHS Foundation Trust, National Institute for Health and Care Research, Farr Institute, University College London
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,800
Funders: National Institute for Social Care and Health Research, Wellcome Trust, Cancer Research UK, National Institute for Health and Care Research, British Heart Foundation, King's College London, University College London, Shire, Versus Arthritis, Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Fogarty International Center
OpenAlex ID: W2786744849